CDMO: Gunggung dhuwit awis saben saham Avid Bioservices Inc

Avid Bioservices, Inc. - logo grafis emiten CDMO

Seamless integration with raw material suppliers minimizes dependency risks, which determines the dynamics of the estimated cash per share for Avid Bioservices, Inc. (CDMO). The value 0.54 represents the current metric, capturing the reallocation of capital. Business stability relies on the shortage of bioreactors and strict FDA oversight, while its role as an indispensable manufacturing facility for cancer drugs makes Avid Bioservices, Inc. (CDMO) a key link in the ecosystem.

CDMO - Dhuwit awis saben saham Avid Bioservices, Inc ing rentang 04.07.2022 - 16.02.2025

Rincian analitis perusahaan Avid Bioservices, Inc.

- rega saiki lan proyeksi nilai saham:
- indikator anane dhuwit lan arus kas:
Ringkesan analisis perusahaan:CDMO (Avid Bioservices Inc)
Produk asli Avid Bioservices

The metric is calculated by dividing total cash and cash equivalents by the number of shares outstanding. This metric determines the internal liquidity reserve, ensuring business resilience during periods of market volatility. For Avid Bioservices, Inc. (CDMO), this capital is critical when implementing automated biosynthesis systems without human intervention. Monitoring cash per share allows for an assessment of the company's financial capacity to scale plant robotization. The indicator's trend confirms the issuer's readiness for technological re-equipment.